MANAGEMENT OF VATAKANTAKA (PLANTAR FASCIITIS) WITH AGNIKARMA: A CASE REPORT

Introduction: Vatakantaka is a painful condition of the heel caused by the vitiation of Vata and Kapha Doshas, which can be correlated with Plantar Fasciitis in modern science. Conventional treatments often provide temporary relief and may be associated with recurrence. Acharya Sushruta has described Agnikarma (therapeutic cauterization) for painful musculoskeletal disorders, particularly when conservative measures fail to provide satisfactory relief. Case Presentation: A 48-year-old male patient presented to the outpatient department with chronic severe left heel pain (VAS score 8/10) for the last six months, associated with marked morning stiffness and a positive Windlass test. Based on clinical findings and radiological assessment, it was diagnosed as Vatakantaka (Plantar Fasciitis). Intervention: The patient was managed with the Agnikarma procedure using a red-hot Panchaloha Shalaka in a Bindu (dot) pattern over the points of maximum tenderness. Four treatment sessions of Agnikarma were administered at an interval of seven days. Outcome: The Visual Analog Scale (VAS) score reduced from 8 to 0 over a period of 50 days. The Foot Function Index (FFI) score improved from 72 to 4, indicating marked improvement in pain and functional ability. Morning stiffness, tenderness, and gait disturbance resolved completely. The Windlass test became negative, and the patient resumed normal daily activities without discomfort. No adverse events or recurrence were reported during the follow-up period. Conclusion: Agnikarma showed considerable improvement in pain and functional ability in this patient. It may be used as a safe and cost-effective treatment option in selected patients.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-16
DOI
https://doi.org/10.5281/zenodo.20731056
Primary Topic
Medical research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MANAGEMENT OF VATAKANTAKA (PLANTAR FASCIITIS) WITH AGNIKARMA: A CASE REPORT

Dr. Khushal Chouhan*1, Dr. Ganesh Belorkar2, Dr. Himanshu3
Zenodo (CERN European Organization for Nuclear Research)
Medical research and treatments
article

MANAGEMENT OF VATAKANTAKA (PLANTAR FASCIITIS) WITH AGNIKARMA: A CASE REPORT

Dr. Khushal Chouhan*1, Dr. Ganesh Belorkar2, Dr. Himanshu3
article en

Abstract

Introduction: Vatakantaka is a painful condition of the heel caused by the vitiation of Vata and Kapha Doshas, which can be correlated with Plantar Fasciitis in modern science. Conventional treatments often provide temporary relief and may be associated with recurrence. Acharya Sushruta has described Agnikarma (therapeutic cauterization) for painful musculoskeletal disorders, particularly when conservative measures fail to provide satisfactory relief. Case Presentation: A 48-year-old male patient presented to the outpatient department with chronic severe left heel pain (VAS score 8/10) for the last six months, associated with marked morning stiffness and a positive Windlass test. Based on clinical findings and radiological assessment, it was diagnosed as Vatakantaka (Plantar Fasciitis). Intervention: The patient was managed with the Agnikarma procedure using a red-hot Panchaloha Shalaka in a Bindu (dot) pattern over the points of maximum tenderness. Four treatment sessions of Agnikarma were administered at an interval of seven days. Outcome: The Visual Analog Scale (VAS) score reduced from 8 to 0 over a period of 50 days. The Foot Function Index (FFI) score improved from 72 to 4, indicating marked improvement in pain and functional ability. Morning stiffness, tenderness, and gait disturbance resolved completely. The Windlass test became negative, and the patient resumed normal daily activities without discomfort. No adverse events or recurrence were reported during the follow-up period. Conclusion: Agnikarma showed considerable improvement in pain and functional ability in this patient. It may be used as a safe and cost-effective treatment option in selected patients.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 5%
Medical research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.